Gobemicina (Ampicillin)

Gobemicina is indicated for the treatment of several bacterial infections where ampicillin is appropriate. It is commonly prescribed in clinical settings for:

• Respiratory tract infections such as pneumonia and bronchitis
• Urinary tract infections caused by susceptible organisms
• Meningitis, particularly in neonates and infants
• Gastrointestinal infections including enteritis
• Skin and soft‑tissue infections like cellulitis and wound infections

Side effects of Gobemicina vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common

• Nausea or vomiting
• Diarrhea or loose stools
• Rash or mild skin irritation
• Local pain at the injection site
• Elevated liver enzymes (transient)

Serious

• Severe allergic reactions (anaphylaxis, angioedema)
• Clostridioides difficile–associated diarrhea
• Hemolytic anemia
• Seizures (rare, high doses)
• Hepatotoxicity with prolonged use

Before using Gobemicina, certain precautions should be considered to ensure safe therapy. Healthcare providers typically evaluate the following:

• History of hypersensitivity to penicillins or other beta‑lactam antibiotics
• Renal or hepatic impairment, which may require dose adjustment
• Pregnancy and breastfeeding status, as safety data are limited
• Concomitant use of anticoagulants, due to potential interaction
• Presence of infectious mononucleosis, which can increase rash risk
• Monitoring for signs of superinfection during prolonged therapy

Gobemicina may interact with other medicines, affecting efficacy or safety. Interactions are grouped by level of concern.

Avoid

• Methotrexate, which can increase toxicity
• Oral contraceptives, potentially reducing contraceptive effectiveness
• Probenecid, which may raise ampicillin plasma concentrations

Use with caution

• Anticoagulants such as warfarin, due to altered INR
• Allopurinol, which may increase rash risk
• Diuretics, which can affect renal clearance of ampicillin